Superselective Citicoline and Verapamil for Ischemic Neuroprotection and Greater Effective Response
Clinical trial NCT02823106 · WITHDRAWN
Trial details
- NCT number
- NCT02823106
- Sponsor
- Justin Fraser
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-01
- Primary completion
- 2016-09-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.